News

First appropriate use criteria for transthoracic echocardiography released for suspected pediatric heart disease


 

References

Appropriate use criteria of transthoracic echocardiography for suspected pediatric heart disease in outpatient settings have been issued for the first time.

The criteria, a collaboration of nine societies, will appear on the websites of the American College of Cardiology, American Society of Echocardiography, and Society for Cardiovascular Angiography and Interventions.

“Of the various diagnostic modalities, echocardiography remains the most readily available, noninvasive, and highly diagnostic tool for assessing cardiac structure, function and hemodynamics in those with suspected cardiac disease,” said Dr. Robert Campbell of Emory University, Atlanta, and his associates. Of the 113 potential indications for first-time use of outpatient transthoracic echocardiography in children and adolescents that they considered, 53 were considered appropriate, 28 possibly appropriate, and 32 rarely appropriate (J. Am. Coll. Cardiol. 2014 Sept. 30 [doi:10.1016/j.jacc.2014.08.003]). The report addressed conditions such as arrhythmias and palpitations, syncope, murmurs, and systemic disorders.

The group collaborated with an Appropriate Use Criteria (AUC) task force and an independent rating panel to produce the report. The criteria do not address posttest follow-up, inpatient pediatric echocardiography, or the assessment of children with known cardiac abnormalities, the authors said.

The writing group reported no funding sources or conflicts of interest. Three members of the rating panel and one member of the AUC task force reported financial relationships with Siemens Medical Systems or Excellus BCBS.

Recommended Reading

FDA expands uses for cardiac resynchronization devices
MDedge Internal Medicine
Intervention manages cardiac patients with depression, anxiety
MDedge Internal Medicine
Insertable monitor reveals AF in 30% of cryptogenic stroke patients
MDedge Internal Medicine
Management of acute atrial fibrillation and atrial flutter in non-pregnant hospitalized adults.
MDedge Internal Medicine
Diabetes increases risk of atrial fibrillation
MDedge Internal Medicine
Rivaroxaban shows advantages in AF cardioversion
MDedge Internal Medicine
High-dose statins don’t prevent postop AF
MDedge Internal Medicine
Wearable defibrillator impresses as bridge to ICD decision
MDedge Internal Medicine
AHA/ACC: No to universal ECG screen in healthy young people
MDedge Internal Medicine
Generic statins topped costlier branded meds in adherence, clinical outcomes
MDedge Internal Medicine